Pharma Reviews: USFDA warnings: Concerns remain even as India fares better than US

Heightened regulatory scrutiny by the US drug regulator for Indian pharma is a concern for the industry. However, long-term data shows that Indian ...
Read more: USFDA warnings: Concerns remain even as India fares better than US